C82.12
Follicular lymphoma grade II, intrathoracic lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Follicular lymphoma is a type of blood cancer that originates in the lymphatic system, which is part of the body's immune defense. When this lymphoma is classified as Grade II, it indicates a moderate level of abnormal cell growth. The designation 'intrathoracic lymph nodes' means that the affected lymph nodes are located within the chest cavity. This form of lymphoma falls under the broader category of non-Hodgkin lymphomas, generally characterized by slow progression and a variety of treatment options. Understanding this specific diagnosis can help patients grasp the nature of their condition and the general treatment approaches.
Causes & Symptoms
Clinical Causes: Genetic mutations within lymphocytes leading to uncontrolled growth Environmental exposures, such as certain chemicals or radiation (though specific causes are often unknown) Immune system dysfunction or suppression Age-related genetic alterations, as it is more common in older adults Family history of lymphoma or other blood cancers
Key Symptoms: Painless swelling or lumps in the neck, armpits, or groin Persistent cough or chest discomfort (due to intrathoracic involvement) Unexplained weight loss Fever without an obvious infection Night sweats Fatigue or weakness Difficulty breathing or chest tightness in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of medical history evaluation, physical examination, and specialized tests. These tests often include imaging studies such as CT scans to identify affected lymph nodes within the chest. A biopsy of the lymph nodes allows for microscopic examination to confirm the presence of follicular lymphoma and determine its grade. Blood tests might also be conducted to assess overall health and detect any related abnormalities. The staging process helps to determine the extent of the disease, guiding treatment decisions.
Treatment Protocols: Watchful waiting: Monitoring the condition without immediate treatment if the disease is slow-growing and asymptomatic Chemotherapy: Use of drugs to kill cancer cells, often combined with immunotherapy Immunotherapy: Treatments that help the immune system recognize and attack lymphoma cells, such as monoclonal antibodies Radiation therapy: Targeted radiation may be used to treat localized disease within the thoracic region Targeted therapy: Medications designed to interfere with specific molecules involved in cancer cell growth
Clinical Advice & FAQs
Billing Guidance
Is C82.12 a billable ICD-10 code?
Yes, C82.12 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.12?
Clinical documentation must specify the nature of Follicular lymphoma grade II, intrathoracic lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference